The authors of the above article have requested its withdrawal, notifying the Journal
that the clinical trials described in the article were not conducted as written in
the article. The Editor-in-Chief, the American Society for Parenteral and Enteral
Nutrition, and the Publisher have determined to retract the article.
Get full access to this article
View all access options for this article.
References
1.
1. Wigmore SJ, Plester CE, Richardson RA, Fearon KC. Changes in nutritional status associated with unrespectable
pancreatic cancer.Br J Cancer.1997;75:106–109.
2.
2. Jatoi A, Windschitl HE, Loprinzi CL. Dronabinol versus megestrol acetate versus combination
therapy for cancer-associated anorexia: a North Central Cancer Treatment Group
Study.J Clin Oncol.2002;20:567–573.
3.
3. Agteresch HJ, Rietveld T, Kerkhofs LGM. Beneficial effects of adenosine triphosphate on nutritional
status in advanced lung cancer patients: a randomised clinical
trial.J Clin Oncol.2002;20:371–378.
4.
4. DeWys WD, Begg C, Lavin PT, Bard PR, et al. Prognostic effect of weight loss prior to chemotherapy
in cancer patients.Am J Med.1980;69:491–497.
5.
5. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when
undergoing chemotherapy for lung cancers?Br J Cancer.2004;90:1905–1911.
6.
6. Costa G, Donaldson SS. Current concepts in cancer: effects of cancer and cancer
treatment on the nutrition of the host.N Engl J Med.1979;300:1471–1474.
7.
7. McAnena OJ, Daly JM. Impact of antitumour therapy on nutrition.Surg Clin North Am.1986;66:1213–1228.
8.
8. Jehn U. [Changing perspectives of parenteral nutrition in cancer
patients: rational and clinical implications].Dtsch Med Wochenschr.2002;127:2682–2688.
9.
9. McNamara MJ, Alexander HR, Norton JA. Cytokines and their role in the pathophysiology of cancer
cachexia.JPEN J Parenter Enteral Nutr.1992;16(6 suppl):50S–55S.
10.
10. Bozzetti F, Gavazzi C, Ferrari P, Dworzak F. Effect of total parenteral nutrition on the protein kinetics
of patients with cancer cachexia.Tumori.2000;86:408–411.
11.
11. Tashiro T, Yamamori H, Takagi K, Morishima Y, Nakajima N. Effect of severity of stress on whole-body protein kinetics
in surgical patients receiving parenteral nutrition.Nutrition.1996;12:763–765.
12.
12. Hagmuller E, Kollmar HB, Gunther HJ, Holm E, Trede M. Protein metabolism in human colon carcinomas: in vivo
investigations using a modified tracer technique with
L-[1-13C]leucine.Cancer Res.1995;55:1160–1167.
13.
13. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing
hepatectomy for he-patocellular carcinoma.N Engl J Med.1994;331:1547–1552.
14.
14. Pisters PW, Pearlstone DB. Protein and amino acid metabolism in cancer cachexia:
investigative techniques and therapeutic interventions.Crit Rev Clin Lab Sci.1993;30:223–272.
15.
15. Heber D, Byerly LO, Chlebowski RT. Metabolic abnormalities in the cancer
patient.Cancer.1985;55(1 suppl):225–229.
16.
16. Holroyde CP, Skutches CL, Boden G, Reichard GA. Glucose metabolism in cachectic patients with colorectal
cancer.Cancer Res.1984;44(12 pt 1):5910–5913.
17.
17. Lundholm K, Edstrom S, Karlberg I, Ekman L, Schersten T. Glucose turnover, gluconeogenesis from glycerol, and
estimation of net glucose cycling in cancer patients.Cancer.1982;50:1142–1150.
18.
18. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF. Cancer cachexia and protein metabolism.Lancet.1984;1:1423–1426.
19.
19. Kern KA, Norton JA. Cancer cachexia.JPEN J Parenter Enteral Nutr.1988;12:286–298.
20.
20. McMillan DC, Watson WS, Preston T, McArdle CS. Lean body mass changes in cancer patients with weight
loss.Clin Nutr.2000;19:403–406.
21.
21. Giacosa A, Frascio F, Sukkar SG, Roncella S. Food intake and body composition in cancer
cachexia.Nutrition.1996;12(1 suppl):S20–S23.
22.
22. Holland JC, Rowland J, Plumb M. Psychological aspects of anorexia in cancer
patients.Cancer Res.1977;37(7 pt 2):2425–2428.
23.
23. Body JJ, Borkowski A. Nutrition and quality of life in cancer
patients.Eur J Cancer Clin Oncol.1987;23:127–129.
24.
24. Bozzeti F. Home total parenteral nutrition in incurable cancer patients:
a therapy, a basic humane care or something in between?Clin Nutr.2003;22:109–111.
25.
25. Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and
dilemmas.Crit Rev Oncol Hematol.2000;34:137–168.
26.
26. Brennan MF. Total parenteral nutrition in the cancer
patient.N Engl J Med.1981;305:375–382.
27.
27. Koretz RL. Parenteral nutrition: is it oncologically
logical?J Clin Oncol.1984;2:534–538.
28.
28. Shamberger RC, Brennan ME, Goodgama JT, et al. A prospective randomized study of adjuvant parenteral
nutrition in the treatment of sarcomas: results of metabolic and survival
studies.Surgery.1984;96:1–13.
29.
29. Copeland EM. Intravenous hyperalimentation and cancer: a historical
perspective.JPEN J Parenter Enteral Nutr.1986;39:105–114.
30.
30. Fischer JE. Adjuvant parenteral nutrition in the patient with
cancer.Surgery.1984;96:578–580.
31.
31. Souba WW, Copeland EM. Hyperalimentation in cancer.Cancer J Clin.1989;39:105–114.
32.
32. Gouttebel MC, Sain-Aubert B, Jonquet O, et al. Ambulatory home total parenteral
nutrition.JPEN J Parenter Enteral Nutr.1987;11:475–479.
33.
33. Muller JM, Keller HW, Brenner U, Walter M, Holzmuller W. [Adjuvant artificial nutrition in tumor
surgery].Infusionsther Klin Ernahr.1986;13:126–132.
34.
34. Charuhas PM, Fosberg KL, Bruemmer B, et al. A double-blind randomized trial comparing outpatient
parenteral nutrition with intravenous hydration: effect on resumption of oral
intake after marrow transplantation.JPEN J Parenter Enteral Nutr.1997;21:157–161.
35.
35. Bachmann P, Marti-Massoud C, Blanc-Vincent MP, et al. [Standards, options and recommendations: nutritional
support in palliative or terminal care of adult patients with progressive
cancer].Bull Cancer.2001;88:985–1006.
36.
36. Ripamonti C, Twycross R, Baines M, et al. Working Group of the European Association for
Palliative Care. Clinical-practice recommendations for the management of bowel
obstruction in patients with end-stage cancer.Support Care Cancer.2001;9:223–233.
38. A.S.P.E.N. Board of
Directors and the Clinical Guidelines Task Force. Guidelines for the use of
parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(suppl):15A-1385A.
Erratum in 2002;26:144.
39.
39. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment
of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical
trials in oncology.J Natl Cancer Inst.1993;85:365–376.
40.
40. Ringdal GI, Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer
patients with heterogeneous diagnoses.Qual Life Res.1993;2:129–140.
41.
41. Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC quality
of life questionnaire.Qual Life Res.1993;2:319–325.
42.
42. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research
and Treatment of Cancer Core Quality-of-Life Questionnaire.J Clin Oncol.1995;13:1249–1254.
43.
43. Kaasa S, Bjordal K, Aaronson N, et al. The EORTC core quality of life questionnaire
(QLQ-C30): validity and reliability when analysed with patients treated with
palliative radiotherapy.Eur J Cancer.1995;31A:2260–2263.
44.
44. Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional status in advanced
metastatic cancer.Support Care Cancer.2003;11:652–659.
45.
45. Khan ZH, Simpson EJ, Cole AT, et al. Oesophageal cancer and cachexia: the effect of
short-term treatment with thalidomide on weight loss and lean body
mass.Aliment Pharmacol Ther.2003;17:677–682.
46.
46. Barber MD, Ross JA, Fearon KC. Cancer cachexia.Surg Oncol.1999;8:133–141.
47.
47. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in
patients with pancreatic cancer.Nutr Cancer.2000;36:177–184.
48.
48. Solassol C, Joyeux H. Artificial gut in gastrointestinal cancer.
In: Zollner N, ed. Beiträge zur Infusionstherapie: Parenterale Ernährung.Basel, Switzerland:
Karger;1978:178.
49.
49. Lindholm E, Daneryd P, Korner U, Hyltander A, Fouladiun M, Lundholm K. Effects of recombinant erythropoietin in palliative treatment
of unselected cancer patients.Clin Cancer Res.2004;10:6855–6864.
50.
50. Grosvenor M, Bulcavage L, Chlebowski RT. Symptoms potentially influencing weight loss in a cancer
population: correlations with primary site, nutritional status, and chemotherapy
administration.Cancer.1989;63:330–334.
51.
51. Nelson KA, Walsh TD, Sheehan FG, O'Donovan PB, Falk GW. Assessment of upper gastrointestinal motility in the
cancer-associated dyspepsia syndrome.Palliât Care.1993;9:27–31.
